Are alpha-blockers involved in lower urinary tract dysfunction in multiple system atrophy?: A comparison of prazosin and moxisylyte
- 15 March 2000
- journal article
- clinical trial
- Published by Elsevier in Journal of the Autonomic Nervous System
- Vol. 79 (2-3) , 191-195
- https://doi.org/10.1016/s0165-1838(99)00105-8
Abstract
No abstract availableKeywords
Funding Information
- Research Committee for Ataxic Disease
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health and Welfare
This publication has 15 references indexed in Scilit:
- Effect of the alpha-adrenergic blocking agent thymoxamine on the neurogenic bladder and urethraActa Neurologica Scandinavica, 2009
- alpha 1-ADRENERGIC RECEPTOR SUBTYPES IN HUMAN DETRUSORJournal of Urology, 1998
- Urinary disturbances in striatonigral degeneration and parkinson's disease: Clinical and urodynamic aspectsMovement Disorders, 1997
- Urodynamic and neurophysiological evaluation in Parkinson's disease and multiple system atrophy.Journal of Neurology, Neurosurgery & Psychiatry, 1997
- Effect of intravenous alfuzosin on urethral pressure in patients with neurogenic bladder dysfunctionNeurourology and Urodynamics, 1996
- Clinical features and natural history of multiple system atrophyBrain, 1994
- Prazosin treatment of neurological patients with lower urinary tract dysfunctionInternational Urogynecology Journal, 1993
- The standardisation of terminology of lower urinary tract functionWorld Journal of Urology, 1989
- Uninhibited Neurogenic Bladder Treated with PrazosinScandinavian Journal of Urology and Nephrology, 1981
- Effect of Phentolamine on Perineal Muscle EMG Activity in ParalegiaBritish Journal of Urology, 1977